Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149227555> ?p ?o ?g. }
- W2149227555 endingPage "429" @default.
- W2149227555 startingPage "424" @default.
- W2149227555 abstract "BackgroundEndovascular stent-graft (ESG) repair of abdominal aortic aneurysm (AAA) has emerged as an alternative to open surgery. The role of ESG in patients with challenging medical and anatomic problems remains an area of general debate. This study reviews an experience with stent grafts to treat patients with AAA and atheromatous embolization syndrome (AES) presenting with chronic distal embolization (CDE).MethodsOver a 5-year period 660 patients with AAA were treated with aortic stent grafts. Patients with AAA and ischemic ulcerations or toe gangrene due to CDE despite palpable foot pulses were investigated for successful aneurysm exclusion, resolution of ischemic symptoms, complications and survival. Follow-up averaged 15.3 ± 14.9 months (range, 1 to 60 months).ResultsNineteen patients had AAA and manifestations of CDE. The population (16 males/3 females) had a mean age of 79 ± 7 years and mean aneurysm diameter of 5.5 cm. Renal insufficiency was present in 5/19 (26 %). Ischemia presented as ischemic ulcers (16/19 [84.2%]) or toe gangrene (3/19 [15.8%]). Stent grafts included 6 aortouniiliac and 13 bifurcated devices. Exclusion was achieved in all but 2 patients who had type II lumbar endoleaks. At 30-day postoperative follow-up, mortality was 0 % and resolution of CDE/ischemia was noted in 2 of 19 (10.5%) patients. Eight of 9 patients with follow-up of 1 year had complete resolution of their ischemic symptoms, with no recurrent manifestations of AES. Complications included progression of renal insufficiency over an 18-month period in 1 patient and an unstable expanding pararenal aortic neck in 1 patient. Foot ischemia persisted at 1 year in a patient with severe coexisting thoracic aortic disease despite successful AAA exclusion. Six (31.6%) patients died during a mean follow-up of 15.3 months from causes unrelated to their AAA.ConclusionOn the basis of this experience, stent-graft repair of AAA and CDE may be an effective strategy to prevent future embolization. Recognition of coexisting thoracic aortic disease is essential. ESG does not address the extremely high morbidity and mortality from cardiovascular causes in this population. Endovascular stent-graft (ESG) repair of abdominal aortic aneurysm (AAA) has emerged as an alternative to open surgery. The role of ESG in patients with challenging medical and anatomic problems remains an area of general debate. This study reviews an experience with stent grafts to treat patients with AAA and atheromatous embolization syndrome (AES) presenting with chronic distal embolization (CDE). Over a 5-year period 660 patients with AAA were treated with aortic stent grafts. Patients with AAA and ischemic ulcerations or toe gangrene due to CDE despite palpable foot pulses were investigated for successful aneurysm exclusion, resolution of ischemic symptoms, complications and survival. Follow-up averaged 15.3 ± 14.9 months (range, 1 to 60 months). Nineteen patients had AAA and manifestations of CDE. The population (16 males/3 females) had a mean age of 79 ± 7 years and mean aneurysm diameter of 5.5 cm. Renal insufficiency was present in 5/19 (26 %). Ischemia presented as ischemic ulcers (16/19 [84.2%]) or toe gangrene (3/19 [15.8%]). Stent grafts included 6 aortouniiliac and 13 bifurcated devices. Exclusion was achieved in all but 2 patients who had type II lumbar endoleaks. At 30-day postoperative follow-up, mortality was 0 % and resolution of CDE/ischemia was noted in 2 of 19 (10.5%) patients. Eight of 9 patients with follow-up of 1 year had complete resolution of their ischemic symptoms, with no recurrent manifestations of AES. Complications included progression of renal insufficiency over an 18-month period in 1 patient and an unstable expanding pararenal aortic neck in 1 patient. Foot ischemia persisted at 1 year in a patient with severe coexisting thoracic aortic disease despite successful AAA exclusion. Six (31.6%) patients died during a mean follow-up of 15.3 months from causes unrelated to their AAA. On the basis of this experience, stent-graft repair of AAA and CDE may be an effective strategy to prevent future embolization. Recognition of coexisting thoracic aortic disease is essential. ESG does not address the extremely high morbidity and mortality from cardiovascular causes in this population." @default.
- W2149227555 created "2016-06-24" @default.
- W2149227555 creator A5021834976 @default.
- W2149227555 creator A5025555296 @default.
- W2149227555 creator A5045681348 @default.
- W2149227555 creator A5050116627 @default.
- W2149227555 creator A5058749919 @default.
- W2149227555 creator A5061030515 @default.
- W2149227555 creator A5071220529 @default.
- W2149227555 creator A5088747314 @default.
- W2149227555 creator A5088942683 @default.
- W2149227555 date "2004-09-01" @default.
- W2149227555 modified "2023-10-17" @default.
- W2149227555 title "The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: Results after a mean of 15 months follow-up" @default.
- W2149227555 cites W1975611569 @default.
- W2149227555 cites W1996164156 @default.
- W2149227555 cites W2009115254 @default.
- W2149227555 cites W2009120299 @default.
- W2149227555 cites W2032464939 @default.
- W2149227555 cites W2035656335 @default.
- W2149227555 cites W2037226587 @default.
- W2149227555 cites W2040599966 @default.
- W2149227555 cites W2044989144 @default.
- W2149227555 cites W2061919575 @default.
- W2149227555 cites W2078386281 @default.
- W2149227555 cites W2080852435 @default.
- W2149227555 cites W2081758327 @default.
- W2149227555 cites W2112019859 @default.
- W2149227555 cites W2119994265 @default.
- W2149227555 cites W2166094921 @default.
- W2149227555 cites W4249241066 @default.
- W2149227555 cites W4301226707 @default.
- W2149227555 doi "https://doi.org/10.1016/j.jvs.2004.06.036" @default.
- W2149227555 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15337868" @default.
- W2149227555 hasPublicationYear "2004" @default.
- W2149227555 type Work @default.
- W2149227555 sameAs 2149227555 @default.
- W2149227555 citedByCount "28" @default.
- W2149227555 countsByYear W21492275552012 @default.
- W2149227555 countsByYear W21492275552013 @default.
- W2149227555 countsByYear W21492275552014 @default.
- W2149227555 countsByYear W21492275552017 @default.
- W2149227555 countsByYear W21492275552018 @default.
- W2149227555 countsByYear W21492275552019 @default.
- W2149227555 countsByYear W21492275552020 @default.
- W2149227555 countsByYear W21492275552021 @default.
- W2149227555 countsByYear W21492275552023 @default.
- W2149227555 crossrefType "journal-article" @default.
- W2149227555 hasAuthorship W2149227555A5021834976 @default.
- W2149227555 hasAuthorship W2149227555A5025555296 @default.
- W2149227555 hasAuthorship W2149227555A5045681348 @default.
- W2149227555 hasAuthorship W2149227555A5050116627 @default.
- W2149227555 hasAuthorship W2149227555A5058749919 @default.
- W2149227555 hasAuthorship W2149227555A5061030515 @default.
- W2149227555 hasAuthorship W2149227555A5071220529 @default.
- W2149227555 hasAuthorship W2149227555A5088747314 @default.
- W2149227555 hasAuthorship W2149227555A5088942683 @default.
- W2149227555 hasBestOaLocation W21492275551 @default.
- W2149227555 hasConcept C126322002 @default.
- W2149227555 hasConcept C141071460 @default.
- W2149227555 hasConcept C2776035437 @default.
- W2149227555 hasConcept C2776098176 @default.
- W2149227555 hasConcept C2776626339 @default.
- W2149227555 hasConcept C2777323849 @default.
- W2149227555 hasConcept C2778583881 @default.
- W2149227555 hasConcept C2779993416 @default.
- W2149227555 hasConcept C2908647359 @default.
- W2149227555 hasConcept C541997718 @default.
- W2149227555 hasConcept C71924100 @default.
- W2149227555 hasConcept C99454951 @default.
- W2149227555 hasConceptScore W2149227555C126322002 @default.
- W2149227555 hasConceptScore W2149227555C141071460 @default.
- W2149227555 hasConceptScore W2149227555C2776035437 @default.
- W2149227555 hasConceptScore W2149227555C2776098176 @default.
- W2149227555 hasConceptScore W2149227555C2776626339 @default.
- W2149227555 hasConceptScore W2149227555C2777323849 @default.
- W2149227555 hasConceptScore W2149227555C2778583881 @default.
- W2149227555 hasConceptScore W2149227555C2779993416 @default.
- W2149227555 hasConceptScore W2149227555C2908647359 @default.
- W2149227555 hasConceptScore W2149227555C541997718 @default.
- W2149227555 hasConceptScore W2149227555C71924100 @default.
- W2149227555 hasConceptScore W2149227555C99454951 @default.
- W2149227555 hasIssue "3" @default.
- W2149227555 hasLocation W21492275551 @default.
- W2149227555 hasLocation W21492275552 @default.
- W2149227555 hasOpenAccess W2149227555 @default.
- W2149227555 hasPrimaryLocation W21492275551 @default.
- W2149227555 hasRelatedWork W17100482 @default.
- W2149227555 hasRelatedWork W2013767293 @default.
- W2149227555 hasRelatedWork W2036903459 @default.
- W2149227555 hasRelatedWork W2088352857 @default.
- W2149227555 hasRelatedWork W2101411592 @default.
- W2149227555 hasRelatedWork W2312335321 @default.
- W2149227555 hasRelatedWork W4225960012 @default.
- W2149227555 hasRelatedWork W4235420789 @default.
- W2149227555 hasRelatedWork W4251619790 @default.
- W2149227555 hasRelatedWork W4362522233 @default.
- W2149227555 hasVolume "40" @default.